Absci’s (ABSI) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Absci (NASDAQ:ABSI – Free Report) in a research report released on ...
bovnews2d
Absci Corp (ABSI) Reported a -2456.69% Operating Margin Last Year—What’s the Real Story?
On Thursday, Absci Corp (ABSI) stock saw a decline, ending the day at $3.68 which represents a decrease of $-0.70 or -15.98% from the prior close of $4.38. The stock opened at $4.5 and touched a low ...
AbSci’s Promising Pipeline and Strategic Execution Drive Buy Rating
Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on AbSci (ABSI – Research Report), retaining the price target of ...
Business Insider3d
Scotiabank Remains a Buy on AbSci (ABSI)
Begin your TipRanks Premium journey today. AbSci (ABSI) Company Description: Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next ...
Industry Survey Reveals Overwhelming Support For AI-Powered Healthcare
At the recent Fortune Brainstorm AI conference held in San Francisco, key leaders in the healthcare industry shared their ...
bovnews5d
Absci Corp (ABSI) Stock: Understanding Its Underlying Value
On Tuesday, Absci Corp (ABSI) stock saw a modest uptick, ending the day at $4.02 which represents a slight increase of $0.81 or 25.23% from the prior close of $3.21. The stock opened at $3.52 and ...
Wall Street Analysts Were Busy This Morning
Real-time index price for TSX Consumer Discretionary Capped Index (TTCD), along with buy or sell indicators, analysis, charts ...
Investing19d
Cathie Wood's ARK ETF shifts focus with major stock trades in AMD and TER
This move is consistent with ARK's recent accumulation of shares in the genomic company. Other notable buys included 167,516 shares of Absci Corp (NASDAQ:ABSI) and 76,644 shares of Pacific Biosciences ...
Investing19d
Cathie Wood's ARK ETF shifts focus with major stock trades in AMD and TER
Other notable buys included 167,516 shares of Absci Corp (NASDAQ:ABSI) and 76,644 shares of Pacific Biosciences (NASDAQ:PACB) of California Inc (NASDAQ:PACB), with total dollar values of $474,070 ...